Eli Lilly

Lilly sales of new diabetes drug accelerate on rising patient demand
BioPharma Dive
Tue, 11/1/22 - 07:10 pm
Eli Lilly
diabetes
Mounjaro
patients
String of gene therapy deals spurs cautious optimism on Wall Street
BioPharma Dive
Tue, 11/1/22 - 07:09 pm
gene therapy
M&A
Akouos
AGTC
Taysha Gene Therapies
Astellas
Eli Lilly
Syncona
Lilly powers through final stretch in critical Alzheimer's race
Fierce Biotech
Tue, 11/1/22 - 07:02 pm
Eli Lilly
Alzheimer's disease
donanemab
lecanemab
Eisai
Eli Lilly revenue inches up 2%, Pfizer raises full year outlook
Medical Marketing and Media
Tue, 11/1/22 - 11:02 am
Eli Lilly
Pfizer
earnings
Systemic lupus erythematosus: major drug trials to watch in 2022 and 2023
Clinical Trials Arena
Mon, 10/31/22 - 10:37 am
clinical trials
systemic lupus erythematosus
AbbVie
ABBV-509
Eli Lilly
LY3471851
Merck KGaA
M5049
Swedish Orphan Biovitrum
emapalumab
Eli Lilly commits $92.5M to Purdue University for pharmaceutical manufacturing scholarships
Layfette Journal and Courier, IN
Fri, 10/28/22 - 10:30 am
Eli Lilly
philanthropy
drug manufacturing
Purdue University
Just announced: upcoming late-stage clinical trials in weight loss and diabetes
Clinical Trials Arena
Sun, 10/23/22 - 07:09 pm
clinical trials
Eli Lilly
Novo Nordisk
weight loss
diabetes
Ozempic
Wegovey
Mounjaro
A startup plans an IPO to give a shelved Lilly drug another shot
BioPharma Dive
Wed, 10/19/22 - 10:39 am
Acrivon Therapeutics
IPOs
Eli Lilly
prexasertib
ovarian cancer
endometrial cancer
bladder cancer
precision medicine
Eli Lilly to buy precision medicine company Akouos for $487M
Medical Marketing and Media
Tue, 10/18/22 - 11:14 am
Eli Lilly
Akouos
M&A
hearing loss
precision medicine
Few safe havens surface in another down quarter for biopharma
EP Vantage
Fri, 10/14/22 - 10:03 am
biopharma stocks
COVID-19
Eli Lilly
Bristol Myers Squibb
Merck
Daiichi Sankyo
Vertex Pharmaceuticals
Takeda
Neurocrine
Sarepta Therapeutics
Orion
Pfizer
GSK
Roche
Moderna Therapeutics
BeiGene
BioNTech
Novavax
CureVac
Eli Lilly tasks Nimbus with hitting a 'high-value' target for diabetes, obesity
Endpoints
Tue, 10/11/22 - 10:33 am
Nimbus
Eli Lilly
diabetes
obesity
The gloom deepens for biopharma stocks
EP Vantage
Mon, 10/10/22 - 06:54 pm
biopharma stocks
AbbVie
Alnylam
AstraZeneca
Biogen
CRISPR Therapeutics
Daiichi Sankyo
Eisai
Eli Lilly
GSK
Intellia Therapeutics
Regeneron
Roche
Sanofi
Sarepta Therapeutics
FDA Review: Alnylam, Cytokinetics, Eli Lilly and More
BioSpace
Sun, 10/9/22 - 06:06 pm
FDA
Alnylam
Cytokinetics
Eli Lilly
Owlet
Boston Cell Standards
Kiromic Biopharma
Entera Bio
Transcenta Holdings
Kira Pharmaceuticals
Kite Pharma
Poxel
Seneca Therapeutics
Schrödinger, Eli Lilly Strike $425M Small Molecule Deal
BioSpace
Sun, 10/9/22 - 06:02 pm
Schrödinger
Eli Lilly
drug development
small molecule drugs
Lilly's tirzepatide slides into FDA fast lane for obesity, turning up heat on Novo Nordisk's Wegovy
Fierce Pharma
Thu, 10/6/22 - 10:59 am
Eli Lilly
Novo Nordisk
obesity
FDA
fast track
tirzepatide
A Biotech Breakthrough Means Big Gains for These 2 Stocks
Motley Fool
Wed, 09/28/22 - 11:02 am
Eli Lilly
Biogen
Alzheimer's disease
lecanemab
donanemab
Lilly sued for age discrimination
Medical Marketing and Media
Tue, 09/27/22 - 11:57 pm
Eli Lilly
legal
EEOC
age discrimination
sales reps
HHS to pay for 60K doses of Eli Lilly's COVID-19 drug following its commercialization
Beckers Hospital Review
Mon, 09/26/22 - 11:29 pm
Eli Lilly
COVID-19
bebtelovimab
federal contracts
HHS
Novartis wins on quantity, but Eli Lilly takes the cake on value of new launches: report
Fierce Pharma
Mon, 09/26/22 - 11:04 am
Novartis
Eli Lilly
drug launches
Mounjaro
With Lilly's Mounjaro set for stardom, an Alzheimer's win would be 'icing on the cake': analysts
Fierce Pharma
Fri, 09/23/22 - 10:48 am
Eli Lilly
type 2 diabetes
obesity
donanemab
Mounjaro
Alzheimer's disease

Pages